Los Angeles, May 17, 2016 — Precision Health Economics (PHE), a global leader in health economic research, policy, and analytics, announced today that Peter Neumann, ScD has joined PHE in the role of principal scientific advisor.
Neumann is an internationally recognized thought leader and innovator in the field of health economics and outcomes research, and one of the nation’s foremost experts in the use of cost-effectiveness research in healthcare decision making. He is the founder and director of the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and has authored more than 200 papers in the medical literature.
“We are thrilled to have Peter as principal scientific advisor,” said Darius Lakdawalla, chief scientific officer of PHE and its parent company, Precision for Value. “Peter’s track record of innovation and leadership in health policy and cost-effectiveness research enhances our core strengths and our ability to meet the changing needs of the market. The question of how best to measure value and cost-effectiveness has taken center stage in market access decisions and in the broader health policy debate.”
Neumann, who will continue in his current role leading Tufts Medical Center’s CEVR team, joins PHE’s advisory team of renowned academic researchers dedicated to supporting life sciences companies that are confronting the challenges of value and cost-effectiveness.
“The Precision team has built a leading platform to address the dynamic challenges of demonstrating and communicating value and outcomes,” said Peter Neumann. “I could not be more pleased to join the Precision Health Economics team in an advisory role in support of their growing base of innovative clients.”
About Precision Health Economics
Precision Health Economics integrates deep technical expertise with practical insights to bring intellectual integrity, academic rigor, and a creative approach to the most challenging problems in healthcare. In addition to its world-renowned team of health economists, PHE draws on the expertise of a network of affiliated academic scientists and clinicians from the world’s leading universities, straddling the policy and clinical arenas to reach top decision makers and influence outcomes. The company has offices in Austin, TX; Boston, Mass.; Los Angeles and Oakland, Calif. For more information, visit www.precisionhealtheconomics.com.
About Precision for Value
Precision for Value supports commercial excellence for global pharmaceutical and life sciences clients through the demonstration and communication of product value and outcomes. The Precision for Value teams provide clients with services grounded in decades of industry knowledge, demonstrated analytics proficiency, and marketing and communications prowess making Precision for Value the preferred strategic partner in the industry. Visit www.precisionforvalue.com for more information.
# # #
Randy Zane, Precision Medicine Group Media Relations
212-686-2650, ext. 3027